author-photo

Armelle Lavole

University of Paris

15

Papers

106

Citations

Citation Trend

Filter By

Papers (10) Sort By

Journal Conference Others

[Rapid outpatient diagnostic pathways for lung cancer: Evaluation after one year].

2021 Revue Des Maladies Respiratoires
Show All
- Source
- Cite
- Save
Citations (0)
Do people living with HIV face more secondary cancers than general population: From the French CANCERVIH network

2021 Bulletin Du Cancer
Show All
- Source
- Cite
- Save
Citations (0)
First-Line Carboplatin Plus Pemetrexed with Pemetrexed Maintenance in HIV+ Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer: The Phase II IFCT-1001 CHIVA Trial.

2020 European Respiratory Journal
Show All
- Source
- Cite
- Save
Citations (5)
Le cancer broncho-pulmonaire : les patients immunodéprimés: Lung cancer in immunodeficient patients

2020 Revue des Maladies Respiratoires Actualités
Show All
- Source
- Cite
- Save
Citations (0)
Ongoing challenges of using immunotherapy in special populations: Poor performance status patients, elderly patients, and people living with HIV.

2020 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (6)
Immunotherapy for cancer in people living with HIV: safety with an efficacy signal from the series in real life experience on behalf of the French CANCERVIH network

2019 AIDS
Show All
- Source
- Cite
- Save
Citations (33)
Role of the YAP-1 Transcriptional Target cIAP2 in the Differential Susceptibility to Chemotherapy of Non-Small-Cell Lung Cancer (NSCLC) Patients with Tumor RASSF1A Gene Methylation from the Phase 3 IFCT-0002 Trial

2019 Cancers
Show All
- Source
- Cite
- Save
Citations (1)
Nonsmall cell lung cancer from HIV-infected patients expressed programmed cell death-ligand 1 with marked inflammatory infiltrates.

2018 AIDS
Show All
- Source
- Cite
- Save
Citations (17)
A DNA-repair prognostic signature for early-stage NSCLC patients, in IFCT-0002 trial of neoadjuvant chemotherapy.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: Results from the IFCT-0802 trial.

2014 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)